- 5 ASC, MOB deals in California
- The Aspen Group’s 3-year growth recap: 40 moves
- How Confusing Financial Journeys Undermine Revenue and Trust
- If AI ‘adds friction, it fails’: How Mayo Clinic scales technology
- As maternity units close, AdventHealth restores OB care in rural Kansas
- Oklahoma officials warn of new opioid
- The new metrics of healthcare technology ROI: What matters to healthcare leaders
- Hoag to launch transplant center in 2027
- MercyOne hospital to transition labor and delivery services
- MercyOne hospital to transition labor and delivery services
- Southeast metros lead US population growth as national gains slow
- 63 most innovative healthcare companies: Fast Company
- 8 Medicare Advantage numbers to know in 2026
- 8 Medicare Advantage numbers to know in 2026
- How a 6-hospital system installed Epic, Workday months apart
- 17 Senate Dems push back on 2027 ACA proposal
- 17 Senate Dems push back on 2027 ACA proposal
- Providence hospital closes inpatient pediatric unit
- Michigan finalizes Medicaid mental health assessment policy changes
- 10 financial notes on USPI’s growth over the past 3 years
- 15 new orthopedic practice, center openings in Q1
- The oral surgery technological revolution
- From Anxiety to Action: How Ambulatory Leaders Are Rebuilding Margins in 2026
- Where GI training may fall short
- What it took to become the world’s first ASC to offer Stryker’s robotic knee tech
- Medtronic’s win in spinal cord stimulator lawsuit upheld
- How the Trump Administration Uses Migrant Kids To Find and Detain Family Members
- Heartland Dental’s 3-year growth recap: 30+ moves
- Cencora’s $10B+ physician acquisition spree: A breakdown
- Tennessee physician practice acquired
- The FTC is coming for healthcare consolidation: 10 things physicians need to know
- Adventist Health sees momentum from insourcing revenue cycle operations
- Unlicensed dentistry cases, DSO deals, legislation & more: 10 dentistry updates in Virginia
- Missouri system debuts mobile behavioral health unit
- Yale researchers study GLP-1’s potential for SUD
- Texas dental school receives $6.5M to expand pediatric dental, medical programs
- North Carolina autism provider to expand therapy access
- $3M Verdict Links Social Media to Anxiety and Depression
- West Virginia hospital to end OB delivery services
- 6 DSOs making headlines
- California hospital’s finances improve, cash position remains ‘dire’
- 1 in 5 metro markets face inpatient monopoly: 7 notes
- Minnesota system faces uncertainty amid Medicare delays
- Ohio county approves behavioral health crisis center plan
- The White House Delays CDC Pick
- New COVID 'Cicada' Variant Is Spreading — What Experts Want You To Know
- Op-ed: Empathy meets efficiency—how the responsible use of AI can transform Medicare
- Family Caregivers Provide $1 Trillion In Annual Labor, AARP Says
- ‘Health Doesn’t Need to Be Ludacris’: Bayer signs rapper-actor to multivitamin campaign
- Rocket plots measured trajectory for new gene therapy Kresladi after clearance to launch from FDA
- Healthy Lab Results May Mask Future Risks for Kids with Obesity
- At-Home Chemotherapy Is Safe, Feasible, Pilot Study Indicates
- What You Do While Sitting Could Predict Dementia Risk
- New Cholesterol Guidelines: What Patients and Caregivers Need to Know
- Want A Bootlicking Yes Man? Ask An AI Chatbot For Advice, Study Warns
- Specially Coated Implants Better For Breast Cancer Patients, Study Finds
- Trump Team Claims Successes Against ACA Fraud While Pushing for More Controls
- Give and Take: Federal Rural Health Funding Could Trigger Service Cuts
- Fierce Pharma Asia—Takeda’s $1.3B reorg; India’s GLP-1 floodgates; Gilead’s $2.2B buy of a China NewCo
- Where are you with EUDAMED?
- Where are you with EUDAMED?
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Why private practice dentistry needs a better model
- CareQuest Innovation Partners, Kno2 collab on medical-dental data integration
- Nonprofit highlights rural opioid care strategies
- Vitana Pediatric & Orthodontic Partners adds Florida practice
- What the Health? From KFF Health News: A Headless CDC
- Rhode Island oral surgeon launches Congressional campaign
- 20 behavioral health leaders challenge industry assumptions
- Recordati confirms it's weighing CVC Capital buyout offer of $12.6B
- 3 California behavioral health centers to close amid funding shifts
- Indiana bars autism therapy provider from Medicaid billing: Wall Street Journal
- UnitedHealth shareholder sues over proposal to include details on integration in annual proxy
- SCAN taps biopharma, CMS vet Aman Bhandari as its first chief AI officer
- Infosys to acquire Optimum Healthcare IT in $465M deal
- DOJ alleges NewYork-Presbyterian forces payers into anticompetitive 'all-or-nothing' contracts
- FDA Warns Biotech Firm Over Cancer Drug Anktiva Claims
- Bees and Hummingbirds May Be Consuming Small Amounts of Alcohol
- Two States Sue Cord Blood Company Over Misleading Claims
- New WHO Guidance Aims To Speed Tuberculosis Testing
- As questions swirl around ATTR competition, Alnylam plots path to market leadership for Amvuttra
- Trump admin delays nomination for new CDC director past deadline
- Outspoken ACIP member steps down amid vaccine panel uncertainty: reports
- Egg-based drugmaker Neion Bio emerges from stealth to cook up multi-product biosimilar collab
- Genentech walks the walk in lupus as sponsor of annual awareness and fundraising event
- Study Reveals How Many Americans Consider Using a Gun
- Massive Study Finds Stress and Grief Don’t Cause Cancer
- Ultra-Processed Foods Harm Fertility In Both Men And Women, Studies Reveal
- Small Daily Habits Can Add Up To Better Heart Health
- Ritalin Might Protect ADHD Kids' Long-Term Mental Health, Study Finds
- Can You Drink Enough Fluids To Prevent Kidney Stones? Maybe Not, New Study Says
- Clasp, loan-linked hiring tool for employers, clinches $20M to expand amid federal loan caps
- Taking a GLP-1? Doctors Say Not To Forget About Movement and Mental Health
- OpenEvidence rolls out AI medical coding feature
- CDC’s Acting Chief Promises a Return to Stability in a Tumultuous Moment
- Remarks at the Financial Stability Oversight Council Meeting
- RWJF: Between 5M and 10M people could lose Medicaid coverage in 2028 under work requirements
- New therapy animal program aims to support 100K patients, providers
- Pulse check on Lilly's GLP-1 fortunes
- Gen Z nurses prioritize schedule flexibility, need more manager interactions to avoid turnover
- How pharma marketers can capitalize on HCPs’ AI, social media and streaming habits
- Federal Officials Investigate States That Require Abortion Coverage
- Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
- Ionis slashes Tryngolza's price tag by 93% ahead of anticipated label expansion
- FDA approves Denali's Hunter syndrome drug, handing rare disease community a win
- Baby Walkers Sold on Amazon Recalled Over Fall Risk
- Want To Protect Your Brain? Science Says Exercise
- HelloFresh Pizza Recall Issued in 10 States Over Metal Risk
- Clinical Trials Have Too Much Data…That’s the Problem.
- Clinical Trials Have Too Much Data…That’s the Problem.
- CMS reveals new Medicaid model that supports coordination for children with complex needs
- Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices
- Takeda targets $1.3B in cost savings in further restructuring
- Biogen pays $20M upfront to tap into Alteogen's subQ delivery tech
- 'Universal Donor' Blood Supplies Dangerously Low, Study Warns
- Why Stepping Outside May Help You Eat Better
- U.S. Medicine, Science Facing An Online Misinformation Siege, Poll Concludes
- Childhood Obesity Undercuts The American Dream For Some, Study Says
- Inclusive High Schools Benefit All Students, Not Just LGBTQ Teens
- Parental Loss Due to Drugs, Violence Raises Child Death Risk by 2,000%
- As Boehringer touts US launches, board chairman worries EU is 'falling further behind'
- The evolving state of exome and genome sequencing
- Demoralized CDC Workforce Reels From Year of Firings, Funding Cuts, and a Shooting
- An Arm and a Leg: Steep Health Care Costs Steer Americans to Tough Decisions
- Qualified Health locks in $125M in fresh funding to scale enterprise AI at health systems
- Misery Loves [Investment] Company?: Remarks at the 2026 Investment Company Institute Investment Management Conference
- Study: Nearly 1 in 5 pediatric hospital deaths involve sepsis
- As expansions come online, CDMO Hovione aims to meet industry's 'dual supply and sourcing' zeal: exec
- Opening Remarks at the Digital Asset Summit 2026
- CVS Caremark, FTC reach settlement in insulin pricing case
- UCB unveils plan to build $2B biologics plant near its US headquarters in Atlanta
- PeaceHealth sued over plans to tap out-of-state staffer ApolloMD for Oregon EDs
- New Lyme Disease Vaccine Shows Strong Results in Trial
- TrumpRx Adds Diabetes, COPD Drugs at Steep Discounts
- Highmark reports $175M net loss for 2025 as financial headwinds batter health plan
- Listen to the Latest ‘KFF Health News Minute’
- Abivax hires commercial chief from Takeda to infuse Entyvio expertise into IBD launch prep
- ImmunityBio hit with FDA warning letter over Anktiva promotions in TV ad, podcast episode
- Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says
- Fewer patients traveled for abortions in 2025 as telehealth care increased, report finds
- Cologuard campaign reunites ‘Full House’ stars to give ‘The Talk’ about colon cancer screening
Dr. Deane Waldman argues from bitter personal experience that wait times are the true measure of health care system effectiveness, not the insured percentage of the population or the patients' costs of health care services that politicians and journalists focus on:
https://spectator.org/wait-times-for-medical-care-matter/
Wait Times for Medical Care Matter
The amount of time it takes to see a physician is the best measure of health care effectiveness.
By Deane Waldman, M.D. - June 22, 2024I am sick and tired of reading headlines about the uninsured rate (i.e. the percentage of people who don’t have health insurance). When it’s down, pundits say Obamacare is working. When it’s up, Democrats claim it is Republicans’ fault for ruining healthcare. Americans care only because that’s what is shouted in their ears and constantly before their eyes: uninsured rate, uninsured rate.
Maximum average wait times for care increased after the ACA to a medically dangerous 122 days for a primary care appointment.
The goal of healthcare is not to have everyone insured. A healthcare system exists solely so provide the services of a medical professional. Not the promise of care but the reality of care, when patients need it.
Complicit media has successfully sold snake oil. They make us believe that coverage — a health insurance policy — equals medical care. If you have the former, you will get the latter. Evidence proves precisely the opposite.
First, people who have no insurance get care through the Emergency Medical Transport and Labor Act of 1986. EMTALA requires hospitals to provide urgent or emergent care for all persons regardless of whether the patient has insurance or does not, i.e., whether the hospital and doctors will be paid for care provided, or not. (READ MORE from Deane Waldman: Government Health Coverage for Illegals is a Bad Idea)
Second, people who have insurance, particularly government-provided insurance, often wait so long for care they die while waiting in line. Such death-by-queue has been reported in Medicaid enrollees as well as veterans covered by Tricare.
The false promise of coverage equals care is exploded by the seesaw effect. As the number of Americans with government insurance goes up, access to care goes down! This inverse (and adverse) consequence is proven by two facts:
1) As Obamacare expanded the Medicaid rolls, fewer doctors were willing to accept these patients for care. Approximately 30 percent are considering early retirement. More demand (for care) with less supply (fewer care givers) produces the seesaw effect.
2) Maximum average wait times for care increased after the ACA to a medically dangerous 122 days for a primary care appointment.
Another metric commonly thrown at the public is cost. That medical costs are too high is obvious by simple observation, by painful direct experience, and by the number of bankruptcies induced by medical bills. When Washington fixes prices, viz., for drugs in Biden’s falsely titled Inflation Reduction Act of 2022, they claim to “make healthcare affordable for all Americans.” Like the mirage that coverage equals care, fixing prices does not make medical care more accessible, in fact, just the opposite.
Price fixing by the government, no matter what is being price-fixed, invariably produces shortages and low quality. History has proven this economic fact. Recall the long lines of people in the U.S.S.R. waiting for “free” shoes, toilet paper, and medical care. Furthermore, fixing low prices for medicines will force pharmaceutical companies to cease research and development. So no new medical miracle drugs. Had Washington fixed drug prices back in the 1970s, today it is likely that children with leukemia would die instead of their 90+ percent cure rate.
Americans are already suffering from price fixing in medical professional services. What the public sees as exorbitant doctor’s charges make great targets for price fixing or even price transparency advocates. A physician’s charges are meaningless in the real world. Medicaid and Medicare issue “allowable reimbursement schedules,” which are lists of predetermined payments for care services, usually a small fraction of the actual charges. Insurance companies and health plans generally follow these schedules when contracting with physicians. And since Washington prohibits physicians from seeking the unpaid balance from patients, doctors are paid whatever Washington says, not what they charged.
When asked why they are refusing to see new Medicaid patients, doctors point to two factors: the low reimbursement schedules, often below their cost-of-doing-business, and the time-wasting, costly regulatory burden. Price fixing strikes again — hurting, not helping, We the Patients.
To offer the public a useful and accurate measure of how well our healthcare system is doing, do not offer the uninsured rate or fixed (low) prices for care. Show us the maximum wait times to get care. The title of an article in the British Medical Journal shows the danger patients face, “Every month delayed in cancer treatment can raise risk of death by around 10%.” Imagine what the current four-month delay is doing. (READ MORE: In Health Care, Job Growth Is Not Always Good)
This author does not need to imagine. My wife waited seven months to see her primary doctor for abdominal pain. The diagnosis was inoperable pancreatic cancer. She died 22 months later. Might her cancer have been operable if her wait time had been four days instead of seven months?
Deane Waldman, M.D., MBA is Professor Emeritus of Pediatrics, Pathology, and Decision Science; former Director of the Center for Healthcare Policy at Texas Public Policy Foundation; former Director, New Mexico Health Insurance Exchange; and author of the multi-award winning book Curing the Cancer in U.S. Healthcare: StatesCare and Market-Based Medicine.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















